IGHE and Friedreich ataxia: This enabled comprehensive and inclusive input as to IgE-mediated FA patients’ experiences, including (1) FA’s natural history, including signs, symptoms, health system experiences, and diagnosis pathways; (2) disease burden and psychosocial impacts on individuals and families; (3) perspectives on treatment attributes, benefits, and clinical trial participation; and (4) topics and resources that patients and caregivers seek regarding FAs.